-The Telegraph New Delhi: The World Health Organisation has announced a plan to approve generic versions of two expensive bio-therapeutic anti-cancer molecules in an effort to make them available to low and middle-income countries. It said it would invite manufacturers to submit applications for pre-qualification of biologically similar versions of rituximab, used to treat chronic lymphocytic leukaemia and non-Hodgkin's lymphoma, and trastuzumab, used to treat breast cancer. The pre-qualification process is a mechanism...

-Firstpost.com Bhupesh Roy is from Assam but he is a long way from home. He has been working in the southern state of Kerala in the construction sector for the past four years and earns around Rs 500 a day, for an average of 20 days a month. “Two months ago, I fell sick. I had food poisoning and was admitted to hospital. I had fever too. For a week, I...

-The Indian Express The rights-based approach departs from the ‘assurance-based approach’ of the new National Health Policy, which essentially perpetuates the status quo, explains The Indian Express. Since the time the Mental Health Bill was introduced in Rajya Sabha in 2013, decriminalisation of suicide has been its calling card. However, the legislation travels beyond just that colonial era relic, assuming a rights-based approach to mental healthcare, and creating circumstances for removal of...

-The Indian Express For the poor, with little cash in the first place, digital promises to ‘swipe’ them out, before their marginalisation is even addressed. Demonetisation is, by its very nature, an autocratic, coercive step. The demonetisation of November 2016 has affected every single Indian. We are, as usual, persuaded to bear the pain and suffering, to “sacrifice” for the nation. The rhetoric continues but it now seems clear that the objective...

-The Telegraph New Delhi: A health consortium today questioned a decision by Delhi High Court earlier this week to quash the Centre's ban on 344 cocktails of two or more medicines and urged doctors across the country to stop prescribing them. The Jan Swasthya Abhiyan (JSA), the Indian section of the global People's Health Movement, said it was shocked at the judgment because there was "no scientific rationale" for the continued use...